About Hanmi

한미약품은 창조와 도전을 기치로 신약개발에 매진하는 R&D중심 제약기업입니다.



  • Feb. Announced 2019 earnings 1.16 trillion won in sales, 18.8% R&D investment against sales
  • JVM Packaging System, Launched in Canadian Walmart
  • Announced 2019 earnings 110.1 billion won, increased 6.3 percent on-year
  • Hanmi announces the largest number of blockbuster products in 2019.
  • Jan. Announced achieving 'Top 1' market share of hypertension medication in Korea
  • A Joint agreement with STANDIME on the Development for new drugs based on AI
  • Hanmi unveiled new R&D strategy at 38th JP Morgan Healthcare Conference
  • Certified International Standard for business countinuity Management System (ISO22301)